Background: The purpose of this preliminary study was to investigate HPA axis function in dissociation. Methods: Nine subjects with DSM-IV depersonalization disorder (DPD), without lifetime ...
In their recent CMAJ Practice article on intranasal corticosteroids, Drs. Fowler and Sowerby1 stated that this therapy is not associated with hypothalamic–pituitary–adrenal (HPA) axis suppression.
News Medical on MSN
Groundbreaking review reveals how gut microbiota influences sleep disorders through the brain-gut axis
A comprehensive review published in Brain Medicine demonstrates that disruptions in gut microbiota composition are closely linked to sleep disturbances across multiple disorders, including insomnia, ...
Testing of hypothalamic-pituitary-end-organ function has advanced remarkably in recent years. As newer tests are compared to the standard ones, it has become apparent that no single test can determine ...
Still, the perennial herb has been used for centuries in Indian Ayurveda traditional medicine, according to the Cleveland ...
Weaving together science, storytelling and evidence-based advice, a new book by Benjamin A. Rein, PhD, clinical assistant professor of psychiatry, reveals why social connection is critical to brain ...
GAITHERSBURG, Md., March 25-Prescription topical corticosteroids may have more potential to cause adrenal suppression than many physicians realize, according to data presented yesterday at an FDA ...
We thank Dr. Kline and colleagues for their insightful comments regarding the potential risk of hypothalamic–pituitary–adrenal (HPA) axis suppression in certain scenarios with nasal corticosteroids. 1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback